ホーム › 大腸癌 › オハイオ › Cincinnati
Cincinnati、OHにおける大腸癌の臨床試験
Cincinnatiとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
被験者募集中第3相
- Oncology Hematology Care - Blue Ash /ID# 280143, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- 他3件
Family Communications After Genetic Testing
被験者募集中健康なボランティア歓迎
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- 他4件
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
被験者募集中第1相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15マイル先
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第2相
- Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15マイル先
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
被験者募集中第2相
- Research Site, Cincinnati
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
被験者募集中第1/2相
- University of Cincinnati Medical Center, Cincinnati
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- University of Cincinnati Cancer Institute, Cincinnati
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
被験者募集中第3相
- Clinical Study Site, Cincinnati
- Clinical Study Site, Cincinnati
- Clinical Study Site, Edgewood · 8マイル先
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
被験者募集中第1相
- University of Cincinnati Cancer Center, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- Cincinnati Children's Hospital Medical Center, Cincinnati
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- University of Cincinnati (UC) - Cancer Institute, Cincinnati
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
被験者募集中第1相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15マイル先
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Oncology Hematology Care Primary, Cincinnati
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
被験者募集中第1/2相
- University of Cincinnati Cancer Center, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- Christ Hospital Cancer Center, Cincinnati
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
被験者募集中第3相健康なボランティア歓迎
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 他1件
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
被験者募集中第1/2相
- Cincinnati Children's Hospital Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
被験者募集中観察研究
- TriHealth Cancer Institute, Cincinnati
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY77件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Philadelphia, PA44件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA38件の研究
- Seattle, WA34件の研究
Cincinnatiにおける他の研究
- 非小細胞肺癌35件の研究
- がん（全種類）27件の研究
- 乳がん25件の研究
- 心不全24件の研究
- 急性骨髄性白血病20件の研究
- 転移性癌20件の研究
- 卵巣がん19件の研究
- 肺がん19件の研究
- 肥満症19件の研究
- 前立腺がん18件の研究
- 多発性骨髄腫17件の研究
- 悪性黒色腫17件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。